FMS

$21.64-0.47 (-2.13%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPROTranscriptsPROStatementsPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$21.64
Potential Upside
69.3%
Whystock Fair Value$36.64
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a ne...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$12.47B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.21
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
4.93%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.92

Recent News

Insider Monkey
Mar 13, 2026

Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations

Fresenius Medical Care AG (NYSE:FMS) is among the best German stocks to buy according to analysts. On February 24, Fresenius Medical Care AG (NYSE:FMS) released its Q4 2025 results. The company posted EPS of €1.14, compared to €0.23 in the same quarter in 2024. It delivered revenue of €5.1 billion, flat from the year-ago quarter. […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 5, 2026

Here's Why Fresenius (FMS) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 26, 2026

Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Softness

What Fresenius Medical Care’s Recent Moves Mean for Investors Fresenius Medical Care (XTRA:FME) has drawn fresh attention after recent share price moves, with the stock down slightly over the past week but showing a small gain over the past month. See our latest analysis for Fresenius Medical Care. The recent 2.8% 30 day share price return contrasts with a weaker year to date share price return of 4.8% and a 1 year total shareholder return of 12.6%, suggesting momentum has been fading...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 25, 2026

FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand

FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Feb 25, 2026

Fresenius Medical Care AG & Co. KGaA Q4 2025 Earnings Call Summary

Moby summary of Fresenius Medical Care AG & Co. KGaA's Q4 2025 earnings call

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.